A preliminary report on the administration of the novel, parenteral HIV fusion inhibitor as a part of a salvage antiretroviral treatment in a hardly-pretreated and multiresistant adolescent with advanced AIDS is presented and discussed on the grounds of experiences in adults, and an update of the literature in this field. Expectations and concerns on the use of this novel anti-HIV compound in pediatric practice are discussed
The role of the novel HIV fusion inhibitor enfuvirtide in multiresistant vertical AIDS treated since birth
MANFREDI, ROBERTO;CALZA, LEONARDO;CHIODO, FRANCESCO
2005
Abstract
A preliminary report on the administration of the novel, parenteral HIV fusion inhibitor as a part of a salvage antiretroviral treatment in a hardly-pretreated and multiresistant adolescent with advanced AIDS is presented and discussed on the grounds of experiences in adults, and an update of the literature in this field. Expectations and concerns on the use of this novel anti-HIV compound in pediatric practice are discussedFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
